Alzheimer’s Drugs Market: Current Analysis and Forecast (2024-2032)

Report Description

Global Alzheimer’s Drugs Market Size & Forecast

The Global Alzheimer’s Drugs Market was valued at ~USD 4.85 billion in 2023 and is expected to grow at a strong CAGR of around ~11% during the forecast period (2024-2032) owing to incentives for developing treatments for rare forms of dementia.

Global Alzheimer’s Drugs Market Analysis

The market size of Alzheimer’s drugs across the globe is expanding because of several factors such as the increasing prevalence of Alzheimer’s disease, particularly among the aging population, which is a significant growth driver. Also advances in medical research and technology have led to the development of new and more effective drugs, which are gaining regulatory approvals and entering the market.

In 2021, a Special Report discussed people’s and doctors’ views on identifying, diagnosing, and treating mild cognitive impairment (MCI), which can be linked to Alzheimer’s disease (AD). Currently, about 6.5 million Americans aged 65 and above have Alzheimer’s dementia. If there are no new treatments to stop, delay, or cure AD, this number could double to 13.8 million.

Global Alzheimer’s Drugs Market Trends

This section discusses the key market trends that are influencing the various segments of the Global Alzheimer’s Drugs Market, as identified by our team of research experts.

Hospital Pharmacy Segment Transforming Industry

Hospital pharmacies play a crucial role in driving the Alzheimer’s drugs market by serving as primary distribution and access points for advanced medications used in the treatment and management of Alzheimer’s disease. They ensure the availability of these specialized drugs, facilitate timely administration, and provide critical support to healthcare professionals in managing patient treatment plans. Additionally, hospital pharmacies are involved in clinical trials and research initiatives, contributing to the development and refinement of new Alzheimer’s therapies. Their close interaction with both patients and healthcare providers enables them to gather valuable real-world data, influencing prescribing practices and fostering the adoption of new and effective Alzheimer’s treatments.

Asia-Pacific is Expected to Grow at a Significant CAGR During Forecast Period

The Alzheimer’s drugs market in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness and diagnosis of the disease, coupled with a rapidly aging population. Countries like Japan, China, and South Korea are at the forefront, investing heavily in healthcare infrastructure and research initiatives aimed at combating Alzheimer’s disease. The region is witnessing substantial investments from both government and private sectors to enhance early detection and develop novel therapeutics. Furthermore, the rising prevalence of Alzheimer’s, along with improving economic conditions and expanding healthcare access, is driving demand for effective treatment options. Collaborative efforts between local and international pharmaceutical companies are fostering innovation and accelerating the development and availability of advanced Alzheimer’s drugs in the region.

Global Alzheimer’s Drugs Industry Overview

The Global Alzheimer’s Drugs Market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new type launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are Biogen; Eli Lilly and Company; Eisai Co., Ltd.; F. Hoffmann-La Roche Ltd; GSK plc.; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and AbbVie Inc.

Global Alzheimer’s Drugs Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, type portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The Global Alzheimer’s Drugs Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Global Alzheimer’s Drugs Market Analysis (2024-2032)

Analyzing the historical market, estimating the current market, and forecasting the future market of the Global Alzheimer’s Drugs Market were the three major steps undertaken to create and analyze the adoption of global Alzheimer’s drugs in major regions. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Global Alzheimer’s Drugs Market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

A detailed secondary study was conducted to obtain the historical market size of the Global Alzheimer’s Drugs Market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Global Alzheimer’s Drugs Market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, end-user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Global Alzheimer’s Drugs Market. Further, we conducted factor analysis using dependent and independent variables such as type, end-user, and regions of the global Alzheimer’s drugs market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and type launches in the Global Alzheimer’s Drugs Market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Global Alzheimer’s Drugs Market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to several factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Global Alzheimer’s Drugs Market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the Global Alzheimer’s Drugs Market in terms of types offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the Global Alzheimer’s Drugs Market. Data was split into several segments and sub-segments after studying various parameters and trends in the type, end-user, and regions in the global Alzheimer’s Drugs Market.

The main objective of the Global Alzheimer’s Drugs Market Study

The current & future market trends of the Global Alzheimer’s Drugs Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the Global Alzheimer’s Drugs Market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
• Segments in the study include areas of the type, end-user, and regions.
• Define and analyze the regulatory framework for the industry.
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the Global Alzheimer’s Drugs Market for the major regions.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the Global Alzheimer’s Drugs Market and the growth strategies adopted by the market players to sustain in the fast-growing market.
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team